Bhangoo

Ronik Bhangoo, MD

Radiation Oncologist

Breast

Genitourinary

Myeloma & Lymphoma

"Dr. Bhangoo and his staff are super. Besides being experts at what they do, they are kind, considerate, friendly and always upbeat. I cannot thank Dr. Bhangoo and his team enough. My future is shining bright."

Dr. Ronik Bhangoo is a Radiation Oncologist and joined Ironwood Cancer & Research Centers in January 2022. Dr. Bhangoo believes in providing high quality, compassionate, and patient-centered cancer care to patients in their own community. He collaborates closely with a multidisciplinary cancer care team to provide patients a comprehensive but individualized approach to treating cancer. Dr. Bhangoo prioritizes a patient’s cancer care goals and recommends treatment options accordingly.

Dr. Bhangoo completed his residency at a nationally ranked cancer center, the Mayo Clinic Arizona. He is trained to treat cancers that arise from all areas of the body and specializes in breast, myeloma & lymphoma and genitourinary malignancies. He utilizes precise image-guided radiotherapy techniques to treat cancer and has published multiple peer-reviewed research articles to help move cancer treatments forward. Dr. Bhangoo looks forward to establishing close relationships with his patients and providing them the best cancer care possible. He has been selected by his professional peers as a Top Doc in PHOENIX Magazine.

Present Title & Subspecialties

Title

Radiation Oncology

Subspecialties

BreastGenitourinaryMyeloma & Lymphoma

Education & Training

Medical School

University of Arizona College of Medicine, Phoenix Arizona

Fellowships

Mayo Clinic College of Medicine, Phoenix Arizona

Cancers Treated

Certifications & Professional Memberships

Board Certified Radiation Oncology
American Society for Radiation Oncology (ASTRO)
American Board of Radiology (ABR)
American Medical Association (AMA)

Publications

Laughlin BS, Bhangoo RS et al. Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone. Front Oncol. 2022 Nov 28;12:925078. PMID: 36518323

Laughlin BS, Bhangoo RS et al. Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience. Front Oncol. 2022 Aug 26;12:920739. PMID: 36091145

Bhangoo RS et al. Radiation recall dermatitis: A review of the literature. Semin Oncol. 2022 Apr;49(2):152-159. PMID: 35585004

Bhangoo RS et al. Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer. Int J Part Ther. 2021 Sep 8;8(4):37-46. PMID: 35530190

Thorpe CS…Bhangoo RS et al. Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry. J Patient Rep Outcomes. 2022 Jan 10;6(1):3. PMID 35006393

Bulman GF, Bhangoo RS et al. Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy. Radiat Oncol J. 2021 Jun;39(2):122-128. PMID: 34619829

Bhangoo RS et al. Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Adv Radiat Oncol. 2021 Mar 2;6(4):100675. PMID: 34409199

Feng H…Bhangoo RS et al. Technical Note: 4D robust optimization in small spot
intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Med Phys. 2021 Aug;48(8):4636-4647. PMID: 34058026

Anderson JD…Bhangoo RS et al. Unplanned implant removal in locally advanced breast cancer. Breast J. 2021 May;27(5):466-471. PMID: 33715231

Yang Y…Bhangoo RS et al. Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity-Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys 2021 Jul 15;110(4):1189-1199. PMID: 33621660

Bhangoo RS et al. Obstructive Rectosigmoid Colon Solitary Extramedullary Plasmacytoma. Dig Liver Dis. 2021 Apr;53(4):496-497. PMID: 33376074

Feng H…Bhangoo RS et al. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy. J Appl Clin Med Phys. 2020 Oct 15;21(11):141-52. PMID 33058523

Bhangoo RS et al. Acute toxicities and short-term patient outcomes after intensity- modulated proton therapy or intensity-modulated photon radiotherapy for esophageal carcinoma: The Mayo Clinic Experience. Adv Radiat Oncol. 2020 May 19; 5(5): 871-879. PMID: 33083649

Liu C…Bhangoo RS et al. Technical Note: Treatment planning system (TPS) approximations matter – comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for non-small cell lung cancer (NSCLC). Med Phys. 2019 Nov; 46(11):4755-4762. PMID: 31498885

Liu C, Bhangoo RS et al. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric- modulated arc therapies. J Appl Clin Med Phys. 2019 Jul; 20(7):15-27. PMID: 31112371

Bhangoo RS et al. Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma. Adv Radiat Oncol. 2018 Oct 12; 4(1):31-34. PMID: 30706007

Parikh CR, Hall IE, Bhangoo RS et al. Associations of perfusate biomarkers and pump parameters with delayed graft function and deceased donor kidney allograft function. Am J Transplant. 2016 May; 16(5): 1526-39. PMID: 26695524

Hall IE*, Bhangoo RS* et al. Glutathione S-Transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function. Am J Transplant. 2014 Apr; 14(4): 886-96. *Both authors are co-first authors. PMID: 24612768

Bhangoo RS et al. Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. Nephrol Dial Transplant. 2012 Aug; 27(8): 3305-14. PMID: 22498916

Joshi MP, Bhangoo RS, Kumar K. Quality of nutrition related information on the internet for osteoporosis patients: a critical review. Technol Health Care. 2011; 19(6): 391-400. PMID: 22129940

Honors & Awards

Top Doctor Award, 2023, PHOENIX Magazine

Marley Endowment Fund (Research Grant), 2020, Mayo Clinic

CV

https://www.ironwoodcrc.com/wp-content/uploads/2022/01/Bhangoo-CV-Updated-1.pdf

Videos

Videos

Languages

Location

Mesa (Arbor)

6111 E. Arbor Ave

Mesa, AZ 85206

Hours:

Monday- Friday

8am-5pm

Contact

480-981-1445

Reviews for Ronik Bhangoo, MD